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In human neutrophils, the synthetic lipopeptide, N-palmitoyl-S-[2,3-bis(palmitoyloxy-(2RS)- 
propyl]-(~)-cysteiny1-(S)-seryl-(S)-lysyl-(S)-lysyl-(S)-lysyl-(~-lysine [Pam,CysSer(Lys),], activates 
NADPH-oxidase catalyzed superoxide (0;) formation through pertussis-toxin-sensitive and per- 
tussis-toxin-insensitive mechanisms (Seifert, R., Schultz, G., Richter-Freund, M., Metzger, J ., 
Wiesmuller, K.-H., Jung, G., Bessler, W. G. & Hauschildt, S. (1990) Biochem. J.  267, 795-802). We 
studied the effects of lipopeptides on differentiation of HL-60 leukemic cells. Pam3CysSer(Lys)4 
enhanced phorbol-l2-myristate-l3-acetate-induced 0; formation (presumably through the ex- 
pression of components of NADPH oxidase) in a concentration-dependent manner with a half- 
maximal effect at 100 ng/ml and a maximum at 1 pg/ml. The effect of the lipopeptide was evident after 
24 h and reached a plateau after 48 h. (2S,6S)-2-Palmitoylamino-6,7-bis(palmitoyloxy)heptanoyl-(S)- 
seryl-(9-lysyl-(9-lysyl-(9-lysyl-(S)-lysine enhanced 0; formation as well. The effects of 
Pam3CysSer(Lys), were potentiated by dibutyryl CAMP, dimethyl sulfoxide, retinoic acid, 1,25-di- 
hydroxyvitamin D3, interferon-y and tumor-necrosis-factor-a. Pertussis toxin, but not its B-oligomer, 
partially inhibited enhanced 0; formation induced by Pam,CysSer(Lys),. 0; formation induced by 
arachidonic acid and y-hexachlorocyclohexane were more sensitive to inhibition by pertussis toxin 
than 0; formation induced by phorbol 12-myristate 13-acetate. Enhanced 0; formation induced by 
dibutyryl cAMP was not affected by pertussis toxin. Unlike ATP, histamine, prostaglandin El and 
the /I-adrenergic agonist, isoproterenol, Pam3CysSer(Lys), did not increase cytosolic Ca2+ ([Ca”],) 
in undifferentiated HL-60 cells. Histamine but not lipopeptides stimulated high-affinity GTPase of 
guanine-nucleotide-binding proteins in membranes of undifferentiated HL-60 cells. In Pam,Cys- 
Ser(Lys),-differentiated HL-60 cells, the responsiveness to the [Ca’ +Ii-increasing agonists, N-formyl- 
L-methionyl-L-leucyl-L-phenylalanine, C5a and leukotriene B4, was increased, whilst the responsive- 
ness to prostaglandin El and isoproterenol was decreased. Pam3CysSer(Lys)4 did not inhibit prolifer- 
ation of HL-60 cells but decreased transferrin receptor expression and increased C3bi receptor 
expression. Pertussis toxin did not affect proliferation and expression of transferrin and C3bi recep- 
tors. Dibutyryl cAMP was considerably more effective than Pam,CysSer(Lys), at inducing alterations 
in the above parameters. Our results suggest that (a) Pam3CysSer(Lys), induces incomplete functional 
differentiation of HL-60 cells through a mechanism which does not depend on a rise in [Ca2+Ii and 
is different from that of other differentiation-inducing substances and (b) the mechanism by which 
Pam3CysSer(Lys), induces differentiation involves pertussis-toxin-sensitive and pertussis-toxin-insen- 
sitive mechanisms. 
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Abhreviutions. Bt’cAMP, dibutyryl CAMP; CJ6-Myc(Ste)Ala, N -  
(2-hexadecyl-3-octadecanoyloxyeicosanoyl)-alanyl; [Ca’ + I i ,  cytosolic 
CaZ + concentration ; fMetLeuPhe, N-formyl-L-methionyl-L-leucyl-L- 
phenylalanine; G-protein, regulatory heterotrimeric guanine- 
nucleotide-binding protein; Gi ,  family of highly homologous G-pro- 
teins (Gi, - Gi3) involvcd in the receptor/agonist-mediated inhibition 
of adenylyl cyclase, activation of phospholipase C in some systems 
(e. g. in HL-60 cells) and stimulation of certain types of ion channels 
(e.g. voltage-dependent K t  and Ca2+ channels); HMD, 1,6-di- 
aminohexane; OF, superoxide anion; Pam,Adh, (2S)-pal- 
mitoylamino - 6,7-bis(palmitoyloxy)heptanoyl; Pam,Ahh, (2s) - 2 - 
palmitoylamino - 6 - palmitoyloxymethyl- 7 - palmitoyloxy - heptano yl ; 
Pam,Cys, N-palmitoyl-S-[2,3-bis(palmitoyloxy)-(2-RS)-propyl]-( R ) -  
cysteinyl; PMA, phorbol 12-myristate 13-acetate. 
Enzymes. GTPase (EC 3.6.1.-); NADPH oxidac (EC 
1.6.99.6). 
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The human promyelocytic cell line, HL-60, is a widely 
employed model system to study various aspects of neutro- 
philic and monocytic differentiation. Among others, retinoic 
acid, dimethyl sulfoxide and dibutyryl CAMP (Bt,cAMP) 
induce certain aspects of neutrophilic differentiation and 1,25- 
dihydroxyvitamin D,, interferon-? and tumor-necrosis-factor- 
CI induce monocytic differentiation. These processes result, to 
different degrees, in decreases of proliferation and expression 
of the transferrin receptor, and in increases of expression of 
C3bi receptors, [Ca2+],-increasing chemoattractant receptors 
and enhanced superoxide ( 0 2 )  formation (for review see 
Harris and Ralph, 1985; Collins, 1987). The precise mechan- 
isms by which very heterogenous substances induce differen- 
tiation, are largely unknown. Interestingly, pertussis toxin 
which ADP ribosylates and functionally uncouples regulatory 
heterotrimeric guanine-nucleotide-binding proteins (G-pro- 
teins) of the G,-family [family of highly homologous G-pro- 
teins (G,l - Gi3) involved in the receptor/agonist-mediated 
inhibition of adenylyl cyclase and activation of phospholipase 
C in some systems (e.g. in HL-60 cells) and stimulation 
of certain types of ion channels (e.g. voltage-dependent K +  
and Ca2+ channels) (for review see Gilman, 1987; Birn- 
baumer et al., 199011 from receptors, partially inhibits retinoic- 
acid-induced enhancement of 0 2  formation in 
HL-60 cells, suggesting that G,-type G-proteins are in- 
volved in this process (Tohkin et al., 1989; Hemmi et al., 
1989). 
The outer cell wall of Gram-negative bacteria contains 
lipoprotein (for review see Braun, 1975). Lipoprotein and 
synthetic analogues derived from its N terminus show various 
biological activities. First, they are effective activators of 
macrophages and lymphocytes (Bessler et al., 1985 ; Hoffmann 
et al., 1989; Hauschildt et al., 1990). Second, immunization 
of guinea pigs with a synthetic low-molecular-mass vaccine 
consisting of a B-cell and T-cell epitope corresponding to a 
partial sequence of foot-and-mouth-disease virus-protein VP1 
covalently linked to N-palmitoyl-S-[2,3-bis(palmitoyloxy)- 
(2-RS)-propyl]-(R)-cysteinyl-(S)-seryl-(~-serine [Pam3Cys- 
(Ser),] protects the host against virus challenge (Wiesmuller 
et al., 1989). Third, synthetic lipopeptides carrying killer cell 
epitopes from influenza nucleoprotein prime virus-specific 
killer cells in vivo (Deres et al., 1989). Finally, we recently 
reported that the synthetic lipopeptide, Pam3CysSer(Lys),, 
induced 0 2  formation and exocytosis in human neutrophils 
(Seifert et al., 1990). The Ser(Lys), moiety was an important 
structural prerequisite for the biological activity of this lipo- 
peptide, as substances devoid of positively charged amino 
acids did not stimulate 0; formation. Lipopeptide-induced 
0; formation was partially inhibited by pertussis toxin, and 
exocytosis was not affected by the toxin at all, suggesting that 
both pertussis-toxin-sensitive and pertussis-toxin-insensitive 
signal-transduction pathways are involved in neutrophil acti- 
vation by Pam,CysSer(Lys)4. All these findings prompted us 
to study the effects of various lipopeptides with positively 
charged amino acid residues on differentiation of HL-60 cells. 
The structural formulae of the lipopeptides studied are shown 
in Fig. 1. We report that Pam,Cy~Ser(Lys)~ induces enhanced 
responsiveness to stimulated 0; formation in HL-60 cells 
(presumably through the expression of components of 
NADPH oxidase) which is partially inhibited by pertussis 
toxin. It also induces increased responsiveness to chemo- 
attractants and changes in expression of transferrin and C3bi 
receptors, but in comparison to Bt2cAMP, functional differ- 
entiation by lipopeptides is incomplete. 
MATERIALS AND METHODS 
Materials 
Pam,CysSer(Lys),, 2R,6R-Pam3CysSer(Lys),, 2R,6S- 
Parn,CysSer(Lys),, Pam3CysSer-tuftsin, Pam3CysSer-I ,6-he- 
xamethylene diamine-tuftsin (Pam3CysSer-HMD-tuftsin), 
(2s) - palmitoylamino - 6,7 - bis(palmitoy1oxy)heptanoyl- Ser- 
(Lys), [Pam,AdhSer(Lys),], (2S,6S)-2-palmitoylamino-6-pal- 
mitoyloxymethyl-7-palmitoyloxyheptanoylSer(Ly~)~ [Pam,- 
AhhSer(Lys),] and N-(2-hexadecyl-3-octadecanoyloxyeicos- 
anoy1)-AlaSer(Lys), [C36-Myc(Ste)AlaSer(Lys)4] were pre- 
pared by chemical synthesis and were unequivocally 
characterized by various analytical and spectroscopic methods 
such as ion-spray mass spectrometry, I3C-NMR spectroscopy 
and chiral-phase amino acid analysis (Metzger and Jung, 
1987; Metzger et al., 1991a,b; Schmidt et al., 1991). Stock 
solutions of lipopeptides (100 or 500 pg/ml) were prepared in 
145 mM NaCl and stored at -20°C. Research quantities of 
lipopeptides are commercially available from Rapp Polymere, 
Tubingen, Germany. Pertussis toxin and its B-oligomer were 
kind gifts of Dr. M. Yajima (Kyoto, Japan). Leukotriene B4 
was provided by Prof. W. Bartmann (Hoechst, Frankfurt/ 
Main, Germany) and 1,25-dihydroxyvitamin D3 was a gift 
from Drs H. Gutmann and U. Fischer (Hoffmann-La Roche, 
Basel, Switzerland). Tuftsin was obtained from Sigma Chemie 
(Taufkirchen, Germany). Human recombinant interferon-? 
and tumor-necrosis-factor-a were from Boehringer Mannheim 
(Mannheim, Germany). Sources of other materials have been 
described elsewhere (Rosenthal et al., 1986; Seifert and 
Schachtele, 1988; Seifert and Schultz, 1987; Seifert et al., 
1989a, b, c, 1990; Offermanns et al., 1989; Serke et al., 1991). 
Cell culture 
HL-60 cells were grown in suspension culture in RPMI- 
1640 medium supplemented with 10% (by vol.) horse serum, 
1 YO (by vol.) non-essential amino acids, 2 mM L-glutamine, 
50 U/ml penicillin and 50 pg/ml streptomycin in a humidified 
atmosphere with 7% C 0 2  at 37°C as described (Seifert and 
Schiichtele, 1988; Seifert et al., 1989a, b). To induce differen- 
tiation, HL-60 cells were seeded at 0.3 cells/nl and were cul- 
tured for different times in the presence of various substances. 
Preliminary studies showed that lipopeptides up to 10 pg/ml 
did not induce staining of HL-60 cells with trypan blue and 
release of lactate dehydrogenase, suggesting that they were not 
toxic (data not shown). Unlike phorbol esters, lipopeptides did 
not induce adherence of HL-60 cells to tissue culture plastic 
flasks suggesting that protein kinase C was not involved in 
lipopeptide-induced differentiation of cells (data not shown). 
Undifferentiated HL-60 cells consisted of < 90% promyelo- 
cytes and incubation with Parn,CysSer(Ly~)~ (1 pg/ml) for 
48 h did not result in morphological maturation as assessed 
by evaluation of Pappenheim-stained cytospin preparations 
of cells (data not shown). Cell counts were performed in a 
hemocytometer. For pertussis-toxin treatment, HL-60 cells 
were seeded at 0.3 cells/nl and were cultured for 24 h in the 
presence of the toxin (0.5 pg/ml), its B-oligomer (0.5 pglml) 
or solvent (control). After that time, pertussis-toxin-induced 
ADP ribosylation of >98% of the cellular GI-type G-proteins 
(Cowen et al., 1990; Wenzel-Seifert and Seifert, 1990). There- 
after, HL-60 cells were treated with different substances for 
various times without changing the culture medium. Sub- 
sequently, HL-60 cells were harvested and functional assays 
were performed. Similar results as those shown in Tables 3 
and 4 were obtained when pertussis toxin was added to the 
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cells simulataneously with the lipopeptides (data not shown). 
Thus, recovery of G, from ADP ribosylation through de novo 
synthesis of G, and/or inactivation of pertussis toxin did not 
satisfactorily explain the differential effects of the toxin on 
stimulated 0; formation. Treatment of HL-60 cells with per- 
tussis toxin or its B-oligomer did not affect cell viability as 
assessed by trypan-blue-dye exclusion and lactate dehydro- 
genase release (data not shown). Treatment of HL-60 cells 
with pertussis toxin or its B-oligomer (0.5 pg/ml) for 24-96 h 
did not result in differentiation of HL-60 cells as measured by 
phorbol-l2-myristate-l3-acetate-(PMA)-stimulated 0, for- 
mation (data not shown). The lipopeptide did not inhibit 
cell growth as measured by proliferation curves. By contrast, 
Bt2cAMP effectively induced cessation of cell growth. Per- 
tussis toxin and its B-oligomer showed no effect on growth 
of HL-60 cells in the absence or presence of Bt,cAMP or 
Pam,Cy~Ser(Lys)~. Analysis of cell-cycle phases revealed a 
considerably greater percentage of control cells and Pam3Cys- 
Ser(Lys)4-treated cells in the S-phase than of Bt2cAMP- 
treated cells (data not shown). 
Table 1. Potentiation by various lipopeptides of Bt2cAMP-induced en- 
hancement of 0; formation in HL-60 cells. HL-60 cells were incubated 
for 48 h in the presence of Bt,cAMP (200 FM) and various substances 
(1 kg/ml each) or solvent (control). HL-60 cells were harvested and 
0; formation was activated with PMA (100 ngiml). Data shown are 
the means S.D. of six experiments performed with different batches 
of HL-60 cells. 
Additives 0; formation 
None 
Parn,CysSer(Ly~)~ 
2R,6R-Pam,Cy~Ser(Lys)~ 
2R,6S-Pam3CysSer(Lys), 
Pam,AdhSer(Ly~)~ 
Pam,CysSer(Ly~)~ + Pam3AdhSer(Lys)4 
Pam, AhhSer(Lys), 
C,6-Myc(Ste)AlaSer(Lys)4 
Pam,CysSer- tuftsin 
Parn,CysSer-HMD-tuftsin 
Tuftsin 
nmoI/I O6 cells 
4.5 & 0.3 
10.3 k 0.5 
10.5 k 0.6 
10.2 k 0.7 
11.2 k 0.5 
11.5 +_ 0.9 
4.3 k 0.6 
4.2 k 0.5 
4.2 k 0.5 
4.1 +_ 0.5 
4.0 0.7 
Assay for 0; generation 
0; formation was monitored at 550 nm by continuous 
measurement of ferricytochrome C reduction inhibitable by 
superoxide dismutase as described (Seifert et al., 1989a, b). 
Unless stated otherwise 0, formation was activated by PMA 
(100 ngiml). In the absence of stimuli, HL-60 cells did not 
generate 0;. The total extent of 0; formation was calculated. 
Measurement of GTPase activity 
GTPase activity was measured according to Offermanns 
et al. (1989) with modifications. Briefly, assay mixtures 
contained membranes from HL-60 cells (10 pg protein/tube), 
0.5 WM [Y-~'P]GTP (4 kBq/tube), 0.5 mM MgCl,, 0.1 mM 
[ethylenebis(oxyethylenenitrilo)]tetraacetic acid, 0.1 mM 
ATP, 1 mM adenosine 5'-[fl,y-imido]triphosphate, 5 mM cre- 
atine phosphate, 40 pg creatine kinase, 1 mM dithiothreitol 
and 0.2% (mass/vol.) bovine serum albumin in 50 mM trietha- 
nolamine/HCl, pH 7.4. After the addition of substances, the 
reaction mixtures were incubated for 3 min at 25 "C. Measure- 
ment of GTPase activity was initiated by the addition of [y- 
32P]GTP. Assays were conducted for 10 min. Stopping of the 
reaction and isolation of Pi were carried out as described 
(Aktories et a]., 1983). Low-affinity GTPase activity was de- 
termined in the presence of GTP (50 pM) and was subtracted 
from total GTPase activity measured in the presence of GTP 
(0.5 pM). Low-affinity GTPase activity in membranes from 
undifferentiated and Bt2cAMP-differentiated HL-60 cells 
amounted to < 5% of total GTPase activity (data not shown). 
Determination of (Ca2+ < i  
[Ca2+Ii was determined using the dye, fura-2 
acetoxymethyl ester, according to the protocol described by 
Wenzel-Seifert and Seifert (1990). Basal [Ca2+Ii in un- 
differentiated and Pam3CysSer(Lys)4-differentiated or 
Bt2cAMP-differentiated HL-60 cells amounted to 90 - 
120 nM and there were no significant differences among these 
groups (data not shown). 
Flow cytometry 
Staining of washed cells and flow cytometry were per- 
formed as described recently (Serke et al., 1991). For detection 
of the C3bi receptor and transferrin receptor, HL-60 cells 
were first incubated with monoclonal antibodies (Leu1 5, anti- 
transferrin receptor) (Becton-Dickinson, Heidelberg, Germa- 
ny) and subsequently with fluorescein-isothiocyanate-conju- 
gated goat anti-mouse IgG (An der Grub, Kaumberg, 
Austria). Cell-cycle phase analysis was performed on ethanol- 
fixed cells stained with propidium iodide following RNAse 
treatment. Analyses were performed in a Facscan flow 
cytometer (Becton-Dickinson). Data were recorded in list 
mode using the Consort 30 software and cell-cycle phase 
analysis was performed using the DNA software (Becton- 
Dickinson). 
Miscellaneous 
Membranes from HL-60 cells were prepared as described 
(Seifert and Schultz, 1987). [JJ-~'P]GTP was synthesized ac- 
cording to Johnson and Walseth (1979). Protein was measured 
according to Lowry et al. (1951) using bovine serum albumin 
as standard. 
Statistics 
assessed using the Wilcoxon test. 
The statistical significance of the effects of substances was 
RESULTS 
Pam,Cy~Ser(Lys)~-enhanced PMA-induced 0; forma- 
tion (presumably through the expression of components of 
NADPH oxidase) in a concentration-dependent manner with 
a half-maximal effect at 100 ng/ml and a maximum at 1 pg/ 
ml (Fig. 2). The effect of the lipopeptide was evident after 24 h 
and reached a maximum after 48 h. Incubations of HL-60 
cells with the lipopeptide for up to 96 h (data shown only for 
up to 72 h) did not further increase PMA-stimulated 0, for- 
mation (data not shown). Pam,CysSer(Lys), was consider- 
ably less effective than Bt2cAMP at enhancing 0; formation. 
However, Pam3CysSer(Lys)4 enhanced the effect of Bt,cAMP 
on stimulated 0; formation by up twofold. In the presence 
of &,CAMP, the effect of the lipopeptide was half-maximal 
at 3 00 ng/ml and was maximal at 1 pg/ml. 
The effects of various lipopeptides on PMA-stimulated 
0; formation were compared (Table 1). The diastereomers, 
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X =Ser-(Lys), 1 H3C-(CH2)l ,-CG-&CHz 
H,c-(cH,) , -co--o-~H 
f H 2  =Ser-Thr-Lys-Pro-Arg 2 
7 3  
= HN-(CHz)6-NH 
AH2 
H ~ c - ( c H ~ ) ~  ,-CGHN-~H-CO-X Ser-Thr-Lys-Pro-Arg 
H3C-(CHZ),,-CC--&CH2 HSC-(CHZ) l,-C+CLCH, 
5 
H~c--(cH,),,-cGc~H H,c-(cH,), 4 - ~ ~ ~ ~ ~ 2 - + ~  
CHZ b H 2  4 
&HZ k H 2  
b H 2  &HZ 
H3C-(CH2)14-CQ-HN-bH-CO-Ser-(Lys), H3C-(CHZ),,-CO-HN-kH-CGSer-( Lys), 
H3C-(CH2),6-CG0 
H3c-(CH2)16-LH CH3 
H,C-(CH,),,-~H-C~HN-C~-GQ-Ser-(iys), 6 
Fig. I .  Structural formulae of lipopcptides. 1, Pam,Cy~Ser(Lys)~ (g ,  2R,6R; b, 2K,6S; a/b, mixture of both diastereomcrs). 2, Pam,CysSer- 
tuftsin. 3, Pam3CysSer-HMD-tuftsin. 4 Pam,AdhSer(Lys),. 5, Pam3AhhSer(Lys),. 6 ,  C36-Myc(Ste)AlaSer(Lys)4. 
. .. 
0 0.01 0.1 1 10 
Parn,Cys-Ser-(Lysf, (pg/rnl) 
Fig. 2. Concentration-dependence and time-dependence of Pam,Cys- 
Ser(Lys),-induced enhancement of 0; formation in HL-60 cells, syner- 
gism with Bt,cAMP. HL-60 cells were incubated for different times 
with Pam,CysSer(Lys), at various concentrations in the absence or 
prcsence of Bt2cAMP (200 pM). HL-60 cells were harvested and 0; 
formation was activated with PMA (100 ngiml). ( W )  Pam3- 
CysScr(Lys), at an incubation time of 24 h;  ( 0 )  Pilm3CysSer(Lys), 
at an incubation time of48 h; (A) Pam,CysSer(Lys), at an incubation 
timc of 72 h;  ( 7 )  Pam,CysSer(Lys), plus Bt,cAMP at an incubation 
time of 48 11. (0) Indicates that Pam,CysSer(Lys), a t  the designated 
concentrations did not significantly enhance 0; formation. Data 
shown are the means f S.D. of for experimcnts performed with 
different batches of HL-60 cells. 
2R,6R-Pam3CysSer(Lys), and 2R,6S-Pam3CysSer(Lys), with 
a different configuration of the asymmetric carbon atom of the 
S-glyceryl part (Fig. l), were similarly effective potentiators of 
Bt,cAMP-induced enhancement of 0, formation as a mix- 
ture of the two diastereomers. Pam3AdhSer(Lys), had the 
same activity as Pam3CysSer(Lys)4 on 0; formation. The 
concentration-response function of Pam3AdhSer(Lys)4-in- 
duced potentiation of 0; formation resembled that of 
Pam,CysSer(Lys), (see Fig. 2; data not shown). The combi- 
nation of Parn,CysSer(Lys), plus Pam3AdhSer(Lys), was not 
Table 2. Synergistic enhancement by Pam,CysSer(Lys), and various 
other substances of 0; formation in HL-60 cells. HL-60 cells were 
incubated for 48 h in the presence of various substances at maximally 
effective concentrations and with combinations of substances. HL-60 
cells were harvested and 0; formation was activated with PMA (100 
ngiml). Undifferentiated HL-60 cells did not generate 0; upon stimu- 
lation with PMA. Data shown are the means f S.D. from five 
experiments performed with different batches of H L-60 cells. 
Additives 0; formalion 
nmoI/I06 cells 
Pam3CysSer(Lys), (1 pg/ml) 1.6 f 0.3 
BtzcAMP (200 pM) 4.8 f 0.6 
Dimethylsulfoxide (1 60 mM) 3.2 0.4 
1.6 f 0.3 Retinoic acid (10 nM) 
1,25-Dihydroxyvitamin D, (10 nM) 2.4 f 0.5 
0.8 +_ 0.2 
Tumor-necrosis-factor-a (300 ujml) 1.5 f 0.4 
10.2 & 1.0 
Pam,Cy~Ser(Lys)~ + dimethylsulfoxide 5.3 f 0.5 
Pam,CysSer(Lys), + retinoic acid 5.4 f 0.3 
Pam,CysSer(Lys), + 1,25-dihydroxyvitamin D3 6.4 & 0.7 
Pam,CysSer(Lys), + interferon-y 5.5 f 0.4 
Pam3CysSer(Lys)4 + tumor-necrosis-factor-a 9.6 f 0.5 
Interferon-y (300 U/ml) 
Pam3CysSer(Lys), + Bt2cAMP 
more effective than each substance alone in enhancing 0; 
formation. Pam3AhhSer(Lys),, C36-Myc(Ste)AlaSer(Lys),, 
Pam,CysSer-tuftsin, Pam3CysSer-HMD-tuftsin and tuftsin 
did not enhance 0; formation in Bt2cAMP-treated HL-60 
cells. The effects of various lipopeptides (1 pg/ml each for 
48 h) on 0; formation were also studied in the absence of 
Bt2cAMP. Under these conditions, Pam,AdhSer(Lys), was 
similarly effective as Pam3CysSer(Lys), and Pam3AhhSer- 
(Lys),, C3,-Myc(Ste)AlaSer(Lys),, Pam3CysSer-tuftsin, 
Pam,CysSer-HMD-tuftsin and tuftsin were ineffective (data 
not shown). 
The interaction of Pam,CysSer(Lys), with various well- 
known differentiation-inducing substances on 0, formation 
was studied (Table 2) .  Pa~n,CysSer(Lys)~ potentiated stimu- 
lated 0; formation in HL-60 cells treated with Bt2cAMP, 
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Table 3. Effect of pertussis toxin and its B-oligomer on enhancement of 
0; formation in HL-60 cells in the presence of BtzcAMP without or 
with Pam,CysSer(Lys)4. HL-60 cells were incubated for 24 h with 
pertussis toxin or its B-oligomer (0.5 pg/ml each) or solvent (control). 
Thereafter, BtzcAMP (100 pM) with or without Pam,Cy~Ser(Lys)~ 
(1 pg/ml) was added to cell cultures and cells were grown for an 
additional 24 h or 48 h without changing the culture medium. Sub- 
sequently, cells were harvested and 0; formation was activated with 
PMA (100 ngiml). Undifferentiated HL-60 cells did not generate 
0, upon stimulation with PMA. Data shown are the means f S.D. 
of five experiments performed with different batches of HL-60 cells. 
Comparison ofpertussis-toxin-treated or €3-oligomer-treated cclls ver- 
sus control cells is shown in the footnotes. 
Additive Incubation 0; formation 
time 
BtZcAMP BtzcAMP + 
Pam,CysSer- 
(LYSI4 
h nmol/1o6 cells 
Control 24 0.9 f 0.3 3.0 f 0.4 
B-oligomer 24 0.8 & 0.2" 2.8 f 0.3" 
Control 48 2.8 + 0.4 6.3 i 0.6 
B-oligomer 48 2.7 f 0.3" 6.1 & 0.5" 
Pertussis toxin 48 2.6 f 0.3" 6.2 & 0.4" 
Pertussis toxin 24 0.9 + 0.4" 1.5 f 0.2b 
Not significant. 
' p  < 0.05. 
dimethyl sulphoxide, retinoic acid, 1,25-dihydroxyvitamin D3, 
tumor-necrosis-factor-a o r  interferon-? for  48 h .  Qualitatively 
the same results were obtained when 0, formation was 
assessed after 24 h and 72 h (data not  shown). 
The effects of  pertussis toxin a n d  its B-oligomer, which 
does not  catalyze A D P  ribosylation of G-proteins (Tamura et 
al., 1983), on 0; formation were assessed. Neither pertussis 
toxin nor its B-oligomer affected Bt,cAMP-induced enhance- 
ment of  0; formation regardless of  whether cells were treated 
with Bt,cAMP for  24 h or 48 h (Table 3). By contrast, per- 
tussis toxin reduced potentiation by Pam3CysSer(Lys), of 
0; formation after an incubation time o f  24 h by about  50%. 
However, after an incubation time of  48 h ,  pertussis toxin 
failed t o  inhibit potentiation by Pam3CysSer(Lys),. Its 
B-oligomer did not  affect potentiation by Pam3CysSer(Lys)4. 
The inhibitory effects of  pertussis toxin o n  0, formation 
induced by P M A ,  arachidonic acid o r  y-hexachlorocyclo- 
hexane in  Pain3CysSer(Lys),-differentiated HL-60 cells were 
compared. I n  agreement with the experiments performed in 
the presence of Bt,cAMP (Table 3), pertussis toxin did not  
significantly inhibit PMA-induced 0; formation in  HL-60 
cells treated with the lipopeptide for  48 h in  the absence of 
Bt,cAMP (Table 4). By contrast, pertussis toxin inhibited 
0, formation induced by arachidonic acid and y- 
hexachlorocylohexane a t  maximally effective concentrations 
in Pam3CysSer(Lys)4-differentiated cells by more than 50%. 
Agonists a t  G-protein-coupling receptors increasc high- 
affinity GTPase activity o f  G-proteins (for review see Gilman, 
1987; Birnbaumer et  al., 1990). Regulation by various sub- 
stances of high-affinity GTPase  in membranes of undifferen- 
tiated and Bt,cAMP-differentiated HL-60 cells was studied 
(Table 5). Differentiation of  HL-60 cells with Bt,cAMP in- 
creased basal GTPase activity by about  60%. In membranes 
of undifferentiated and  differentiated HL-60 cells, N-formyl- 
L-methionyl-~-leucyl-~-phenylalanine (MetLeuPhe)  stimu- 
Table 4. Differential pertussis toxin-sensitivity of Pam3CysSer(Lys)4- 
induced enhancement of 0; formation in HL-60 cells. HL-60 cells were 
incubated for 24 h with pertussis toxin (0.5 pg/ml) or solvent (control). 
Thereafter, Pam3CysSer(Lys)4 (1 pg/ml) was added to cell cultures, 
and cells were grown for an additional 48 h without changing the 
culture medium. Subsequently, cells were harvested and 0; formation 
was stimulated with arachidonic acid (160 pM), y-hexachlorocyclo- 
hexane (0.5 mM) or PMA (100 ng/ml). Undifferentiated HL-60 cells 
did not generate 0; upon stimulation with these substanccs. Data 
shown are the means f S.D. of five experiments performed with 
different batches of HL-60 cells. Comparison of pcrtussis-toxin- 
treated cells versus control cells is shown in the footnotes. 
Stimulus 0; formation 
control pertussis toxin 
(nmol/l O6 cells) 
None (control) 0 0 
0.9 t 0.2 0.4 & 0.1' Arachidonic acid 
y-Hexachlorocyclohexane 1 .O f 0.3 0.4 & 0.2' 
PMA 1.7 0.3 1.5 f 0.3" 
Not significant. 
b p  < 0.05. 
Table 5. Effects of various substances on high-affinity GTPase activity 
in membranes of undifferentiated and BtlcAMP-differentiated HL-60 
cells. Membranes from undifferentiated H L-60 cells and HL-60 cells 
treated with BtzcAMP (200 pM) for 48 h were prepared and high- 
affinity GTPase activity was measured in the absence or presence of 
various substances. Data shown are the means & S.D. of assay 
quintuplicates. Similar results were obtained in four independent ex- 
periments. Comparison of the effects of substances versus control is 
shown in the rootnotes. n.d., not delermincd. 
Addition GTPase activity 
undifferentiated Bt,cAMP- 
differentiated 
~ _ _ _ _ _ _ _ ~ _ _ _ _ _ _ _ _  ______ ~ ~ ~ 
pmol Pi. mg- '  . min-'  
~~~ ~ 
None (control) 11.4 f 0.3 18.2 f 0.4 
fMetLeuPhe (10 pM) 13.1 & 0.5' 41.9 f 1.5' 
Histamine (1 mM) 13.7 -t 0.4" 22.0 f 0.4' 
Pam,Cy~Ser(Lys)~ (100 pg/ml) 11.3 & 0.5" 17.9 + 0.7" 
Parn,AdhSer(Ly~)~ (100 pg/ml) 9.9 f 0.3" n.d. 
a Not significant. 
' p  < 0.05. 
c p  < 0.01. 
lated GTPase activity by 15% and 130%, respectively, and 
histamine stimulated enzyme activity in both types of  mem- 
branes by about  20%. Pam,CysSer(Lys), a t  1, 10 a n d  100 pg/ 
ml (data shown only for  100 pg/ml) showed n o  effect on high- 
affinity GTPase activity in membranes of  Undifferentiated and 
differentiated HL-60 cells. Pam,AdhSer(Lys), (100 pg/ml) 
inhibitcd high-affinity GTPase activity in membranes of  un- 
differentiated HL-60 cells by 13% a n d  this lipopeptide a t  1 pg/ 
ml and  10 pg/ml was without effect (data not shown). 
The effects of various substances o n  [Ca2+Ii in un- 
differentiated HL-60 cells were assessed. ATP induced a large 
and sustained increase in  [Ca2+], (Fig. 3). In comparison to  
ATP, histamine and  prostaglandin El  induced considerably 
smaller and more transient increases in [Ca2+Ii. Pertussis 
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Fig. 3. Effect of various substances on [CaZ+li in undifferentiated 
HL-60 cells. Undifferentiated HL-60 cells were loaded with fura-2- 
acetoxymethylester, and [CaZtIi was determined. At t = 0 min, vari- 
ous substances were added to cells. Trace 1, pertussis toxin or its 
B-oligomer (0.5 pg/ml each), Parn,CysSer(Lys),, Pam3AdhSer(Lys), 
or Pam,AhhSer(Lys), (1 and 10 pg/ml each); trace 2, prostaglandin 
E l  (10 pM); trace 3, histamine (100 pM); trace 4, ATP (100 pM). 
Superimposed original tracings from one experiment are shown. Simi- 
lar results were obtained in three experiments with different batches 
of HL-60 cells. 
I I 
o h l ~ 1 0  -9 8 7 6 
fMet-Leu-Phe (-log M) C5a (-log M) LTB, (-log M) 
Fig. 4. Effect of chemoattractants on [Caz+li in HL-60 cells. HL-60 
ceIls were incubated for 48 h in the presence of Parn,CysSer(Lys), 
( 1  pg/ml), Bt,cAMP (200 pM) or solvent (control). Cells were harvest- 
ed, loaded with fura-2-acetoxymethylester and [Ca' 'Ii was deter- 
mined. Chemoattractants were added to cells and the increase in 
[CaZ 'Ii was determined. ( 0 )  Undifferentiated HL-60 cells; (A) Pam3- 
CysSer(Lys),-differentiated cells; ( W )  BtZcAMP-differentiated HL- 
60 cells. (0) Indicates that chemoattractants at the designated concen- 
trations did not significantly increase [Ca2+Ii. Data shown are the 
means '. S.D. of four experiments performed with different batches 
of HL-60 cells. LTB,, leukotriene Bq. 
toxin, its B-oligomer, Pam3CysSer(Lys)4, Pam3AdhSer(Lys)4 
and PamjAhhSer(Lys)4 showed no effect on [Ca2+Ii. 
In undifferentiated HL-60 cells, fMetLeuPhe and leuko- 
triene B4 were almost ineffective to increase [Ca2+Ii and C5a 
was only weakly effective (Fig. 4). Differentiation of HL-60 
cells by Bt2cAMP was accompanied by a large enhancement 
in potency and effectiveness of these chemoattractants to in- 
crease [Caz+li. Pam,CysSer(Lys), also induced increased re- 
sponsiveness to chemoattractants, especially to fMetLeuPhe 
Table 6. Effect of various substances on ICaZ+li n HL-60 cells. HL-60 
cells were incubated for 48 h in the presence of Pam3CysSer(Lys)4 
(1 pg/ml), BtzcAMP (200 pM) or solvent (control). Cells were harvest- 
ed and the increase in [CaZfIi induced by various substances was 
assessed. Data shown are the means f S.D. of five experiments 
performed with different batches of HL-60 cells. Comparison of dif- 
ferentiated versus undifferentiated cells is shown in the footnotes. 
Stimulus Increase in [CaZ+Ii 
control Pam,CysSer(Lys), Bt,cAMP 
nM 
ATP (100 pM) 1105 f 112 1098 & 98" 1204 k 102" 
Concanvalin A 
(1 00 Pg/ml) 49 & 10 52 + 8. 152 _+ 25b 
Prostaglandin E 
Isoproterenol 
(10 PM) 56 & 18 21 f 4b 11 f 5h 
11 lob (10 PM) 39 8 19 & 1b 
a Not significant. 
b p  < 0.05. 
transferrin receptor Cdbi receptor 
fluorescence fluorescence 
Fig. 5. Expression of transferrin and C3bi receptors in HL-60 cells. 
HL-60 cells were incubated for 48 h in the presence of Pam3Cys- 
Ser(Lys), (1 pg/ml), BtZcAMP (200 pM) or solvent (control). Cells 
were harvested and the expression of transferrin and C3bi receptors 
was determined by flow cytometry. In each sample, 5000 cells were 
analyzed. Typical fluorescence diagrams from one experiment are 
shown. Similar results were obtained in five experiments performed 
with different batches of HL-60 cells. 
and C5a, but its effects were less pronounced than those of 
Bt2cAMP. 
The effects of various substances employed at maximally 
effective concentrations in undifferentiated and Pam,CysSer- 
(Lys),-differentiated or Bt2cAMP-differentiated HL-60 cells 
on [Ca2+Ii were studied (Table 6). Differentiation by either 
substance was not associated with alterations in responsive- 
ness to ATP. Treatment with Bt,cAMP, but not with the 
lipopeptide, increased the responsiveness to concanavalin A, 
whereas differentiation by both substances decreased 
rsponsiveness to prostaglandin El and isoproterenol. 
Differentiation of HL-60 cells with Pam,Cy~Ser(Lys)~ and 
Bt,cAMP decreased the percentage of transferrin-receptor- 
positive cells from 44% to 30% and 3%, respectively (Fig. 5) .  
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In the presence of the lipopeptide and Bt2cAMP, the percent- 
age of C3bi-receptor-positive cells increased from 2% to 7% 
and 26%, respectively. Pertussis toxin and its B-oligomer did 
not affect the expression of transferrin and C3bi receptors in 
undifferentiated and lipopeptide-differentiated or Bt,cAMP- 
differentiated HL-60 cells (data not shown). Treatment of 
HL-60 cells with Bt,cAMP (100 pM) plus Pam3CysSer(Lys), 
(1 pg/ml) for 48 h resulted in synergistic expression of the C3bi 
receptor (data not shown). 
DISCUSSION 
In this report, we show that the synthetic lipopeptide, 
Pam3CysSer(Lys),, in comparison to Bt'cAMP, induces in- 
complete functional differentiation of HL-60 cells as assessed 
by enhanced 0; formation (Fig. 2, Table l), altered respon- 
siveness to [Ca' +],-increasing substances (Fig. 4, Table 6) and 
decreased expression of transferrin- and increased expression 
of C3bi receptors (Fig. 5). 
In order to study the mechanism by which lipopeptides 
induce functional differentiation, we compared the effects of 
Pam3CysSer(Lys), with those of other lipopeptides containing 
positively charged amino acids (Fig. 1). One group of lipo- 
peptides studied differs in the structure of the lipid moiety but 
not in the pentapeptide chain, Ser(Lys),. This group compri- 
ses 2R,6R-S-Pam3Cys-Ser(Lys),, 2R,6R-Pam3CysSer(Lys),, 
2R,6S-Pam3CysSer(Lys),, Pam3AdhSer(Lys)4, Pam3Ahh- 
Ser(Lys), and C,,-My~(Ste)AlaSer(Lys)~. The other group 
comprises the tuftsinyl derivatives, Pam3CysSer-tuftsin and 
Pam3CysSer-HMD-tuftsin. Unlike some of the Ser(Lys),- 
containing lipopeptides, neither tuftsin nor its lipopeptide de- 
rivatives enhanced 0; formation (Table 1). Our results 
suggest that the presence of two positively charged amino acid 
residues with or without PamjCysSer is not sufficient for 
activation and that Ser(Lys), plays a crucial role in differen- 
tiation of HL-60 cells by lipopeptides. However, the presence 
of Ser(Lys), is also not sufficient for lipopeptide-induced acti- 
vation of HL-60 cells, as only Pam3CysSer(Lys), and Pam3- 
AdhSer(Lys), induced differentiation, whereas Pam3AhhSer- 
(Lys), and C,,-Myc(Ste)Ala-Ser(Lys), are ineffective. Thus, 
the structure of the lipid moiety of lipopeptides also deter- 
mines their effectiveness to enhance 0, formation. The con- 
figuration of the asymmetric carbon atom of the glyceryl 
moiety of Pam,CysSer(Lys), is apparently not critical, since 
the mixture of diastereomers and the pure 2R,6R and 2R,6S 
diastereomers of Pam3CysSer(Lys), had comparable effects 
on 0; formation. In addition, substitution for the sulfur in 
Pam3CysSer(Lys), by a methylene group in Pam3AdhSer- 
(Lys), did not alter the potency and effectiveness of the lipo- 
peptide to enhance 0; formation, but the insertion of a meth- 
ylene group between the palmitoyloxy residue and the asym- 
metric carbon atom of the glyceryl residue in Pam,Ahh- 
Ser(Lys), resulted in complete loss of differentiation-inducing 
activity. The mycoloyl amino acid derivative, C,,-Myc(Ste)- 
AlaSer(Lys),, which differs substantially from Pam3CysSer- 
(Lys), in the lipid moiety, did not enhance 0: formation. All 
these results suggest that the structure of both the lipid moiety 
and of the positively charged amino acid chain are important 
for activation of HL-60 cells by lipopeptides and that these 
substances do not act in an unspecific manner. The lack of 
synergism between Pam3CysSer(Lys), and Pam3AdhSer- 
(Lys), indicates that both lipopeptides act through a mech- 
anism they have in common (Table 1). 
The fact that Pam,Cy~Ser(Lys)~ potentiated enhanced 
0; formation induced by Bt2cAMP, retinoic acid, dimethyl 
sulphoxide, 1,25-dihydroxyvitamin D3, tumor-necrosis-fac- 
tor-a and interferon-y, suggests that the lipopeptide-induces 
differentiation by a mechanism distinct from that of the above 
substances (Table 2). Synergistic interaction of different sub- 
stances to induce differentiation of HL-60 cells was also ob- 
served by other groups (Olsson et al., 1982; Weinberg and 
Larrick, 1987; Breitman and He, 1990). Unlike, ATP, hista- 
mine and prostaglandin El, Pam3CysSer(Lys), did not in- 
crease [Ca' 'Ii in undifferentiated HL-60 cells indicating that 
calcium is not an early signal in lipopeptide-induced differen- 
tiation (Fig. 3). These results also suggest that lipopeptides 
induces differentiation of HL-60 cells through a mechanism 
different from that of ATP, histamine and prostaglandin El 
(Chaplinski and Niedel, 1982; Olsson et al., 1982; Tasaka et 
al., 1990; Cowen et al., 1991). 
We investigated the question whether pertussis-toxin-sen- 
sitive G-proteins are involved in lipopeptide-induced enhance- 
ment of 0, formation in HL-60 cells. Unlike in various other 
systems, pertussis toxin and its B-oligomer neither increased 
[Ca"], nor affected proliferation (Fig. 3, and Materials and 
Methods) (Tamura et al., 1983; Strnad and Carchman, 1987; 
Sommermeyer and Resch, 1990). Pertussis toxin may increase 
cAMP levels through a blockade of the function of Gi (Katada 
and Ui, 1979; Murayama and Ui, 1983). Unlike Bt2cAMP, 
pertussis toxin did not induce differentiation of HL-60 cells 
and did not inhibit cell growth (see Materials and Methods). 
Additionally, Bt,cAMP potentiated lipopeptide-induced en- 
hancement of 0; formation, whereas pertussis toxin was in- 
hibitory or without effect (Fig. 2, Tables 3 and 4). Hemmi et 
al. (1989) reported that pertussis toxin did not increase cAMP 
levels in HL-60 cells. All these results suggest that the effects 
of pertussis toxin on differentiation of HL-60 cells were not 
due to Ca2+ influx from the extracellular space but rather due 
to ADP ribosylation of Gi-proteins which did not result in the 
imitation of the effects of Bt2cAMP. 
Both, retinoic-acid-induced and Pam3CysSer(Lys),-in- 
duced enhancements of 0; formation were partially inhibited 
by pertussis toxin (Tables 3 and 4) (Tohkin et al., 1989; Hemmi 
et al., 1989). The notion that the effects of pertussis toxin on 
lipopeptide-induced enhancement of 0, formation were me- 
diated through ADP ribosylation of G-proteins is supported 
by the finding that its B-oligomer did not mimick its effects 
(Table 3). Intriguingly, the effects of Pam3CysSer(Lys)4 on 
differentiation were not uniformly inhibited by pertussis toxin. 
With PMA as the stimulus, 0, formation was less sensitive 
to inhibition by pertussis toxin than with y-hexachlorocyclo- 
hexane or arachidonic acid as stimuli (Table 4) and pertussis 
toxin did not affect alterations in expression of C3bi and 
transferrin receptors induced by Pam3CysSer(Lys)4. This dif- 
ferential and only partial sensitivity to inhibition by pertussis 
toxin of differentiation is reminiscent of the effects of pertussis 
toxin on lipopeptide-induced 0: formation and exocytosis in 
human neutrophils (Seifert et al., 1990). The stimulus speci- 
ficity of the effects of pertussis toxin on lipopeptide-induced 
enhancement of 0; formation may be due, at least in part, to 
the fact that PMA, y-hexachlorocyclohexane and arachidonic 
acid activate 0; formation through different mechanisms 
(Badwey et al., 1984, English et al., 1986; Tauber, 1987), 
possibly involving different regulatory and/or structural 
components of NADPH oxidase. At present, it is not yet 
known whether lipopeptides interact with ADP ribosylated 
G-proteins of the Gi  family and/or pertussis-toxin-insensitive 
G-proteins (Strathmann and Simon, 1990) and/or low-molec- 
ular-mass GTP-binding proteins (Bokoch and Parkos, 1988). 
Similar to the effects of purine and pyrimidine nucleotides in 
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HL-60 cells, the ones of lipopeptides are partially pertussis- 
toxin-insensitive (Tables 3 and 4) (Dubyak et al., 1988; Seifert 
et al., 1989a; Cowen et al., 1990; Wenzel-Seifert and Seifert, 
1990). Additionally, pertussis toxin inhibits ionophore A- 
23 187-induced but not PMA-induced prostaglandin and 
leukotriene release in murine macrophages treated with lipo- 
polysaccharide (Matsunaga et al. 1990). 
The increases in basal high-affinity GTPase activity and 
stimulation by MetLeuPhe in membranes from Bt2cAMP- 
differentiated HL-60 cells may be explained by both increased 
expression of GI-type G-proteins and formyl peptide receptors 
(Table 5)  (Chaplinski and Niedel, 1982; Murphy et al., 1987). 
In  membranes of undifferentiated and differentiated HL-60 
cells, histamine substantially stimulated high-affinity GTPase. 
Unlike NetLeuPhe and histamine, Pam3CysSer(Lys)4 did 
not affect GTPase activity in HL-60 membranes and Pamj- 
AdhSer(Lys), significantly reduced basal high-affinity 
GTPase activity. Thus, the failure of lipopeptides to stimulate 
GTPase in membranes of undifferentiated HL-60 cells cannot 
be explained by the absence of G-proteins. These results and 
those on the regulation of [Ca”], (Fig. 3) suggest that in HL- 
60 cells, lipopeptides interact with G-proteins in a manner 
different from that of agonists at various G-protein-linked 
receptors, i. e. formyl peptide-, nucleotide, histamine, prosta- 
glandin and p-adrenergic receptors. 
There are structural and functional similarities between 
lipopeptides, mastoparan of wasp venom and substance P (for 
review see Mousli et al., 1990b). All these substances bear 
positive charges and possess hydrophobic domains. In neutro- 
phils, mastoparan, substance P and Pam3CysSer(Lys), 
mimick certain aspects of agonist-induced cell activation and 
the effects of either substance are only partially inhibited by 
pertussis toxin (Serra et al., 1988; Perianin and Snyderman, 
1989; Seifert et al., 1990). It has been shown that substance 
P and mastoparan directly activate G-proteins, possibly by 
mimicking the effects of basic loops of plasma-membrane 
receptors (Higashijima et al., 1988; Mousli et al., 1990a). 
These results raise the possibility that lipopeptides do not 
necessarily act through plasma-membrane receptors but 
through the direct activation of G-proteins. However, unlike 
mastoparan and substance P, Pam3CysSer(Lys)4 did not 
stimulate high-affinity GTPase of Gi-type G-proteins and 
Pam3AdhSer(Lys), was moderately inhibitory in this respect 
(Table 5) (Higashijima et al., 1988; Mousli et al., 1990a). 
Finally, it cannot be excluded that the effects of lipopeptides 
on differentiation of HL-60 cells, by analogy with the ones of 
retinoic acid (Nervi et al., 1989), are mediated through nuclear 
receptor proteins, as the former substances rapidly enter the 
nucleus (Wolf et al. 1989). Thus, our results clearly emphasize 
the need for additional work to reveal the precise mechanism 
by which lipopeptides induce functional differentiation of 
HL-60 cells. 
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